Mission statement · Company scope
“Our mission is to build the leading coagulation company by discovering, developing, and commercializing innovative therapies for the millions of patients worldwide suffering from serious bleeding and thrombotic diseases.”
In use2026 – now1 sighting
First seenMay 2026Added
Last seenMay 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Market leadership (primary) · Innovation · Product offering
- Leads with
- Rank
- Best for
- Climate & health
- Formula
- The [rank] [category] for [who]
- Tone
- Aspirational
- Length
- 29 words · reading grade 20.9
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.75
- Record
- st_66a8a0cb32a96177
- Classification confidence
- 0.71
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-05-01 · sec_sentence · 424B4 · accession 0001193125-26-201458
View filing ↗0 to compareCompare